Abstract:Background and Objectives The isolation of neutrophils and subsequent detection of anti‐human neutrophil antigens (HNA) antibodies are crucial in clinical medicine for the diagnosis of autoimmune neutropenia, neonatal alloimmune neutropenia (NAIN) and transfusion‐related acute lung injury (TRALI). This study reports two cases of maternal anti‐Fc‐gamma‐receptor‐IIIb (FcγRIIIb) isoimmunization without NAIN symptoms and compares the efficiency of immunomagnetic negative selection (IMNS) with traditional dextran/Ficoll for neutrophil isolation in HNA serological assays. Materials and Methods Investigating two cases of maternal anti‐FcγRIIIb isoimmunization, neutrophils from three donors were isolated from 8 mL of whole blood using IMNS and dextran/Ficoll. Serological assays included the granulocyte agglutination and immunofluorescence test, monoclonal antibody immobilization of granulocyte antigens and the LABScreen Multi (One Lambda). IMNS and dextran/Ficoll were compared in terms of cell yield, viability, time, cost and purity. Results Maternal anti‐FcγRIIIb isoantibodies with FCGR3B gene deletion were detected in both cases. Newborns and fathers exhibited specific gene combinations: FCGR3B*02/FCGR3B*02 (Case 1) and FCGR3B*02/FCGR3B*03 (Case 2). IMNS outperformed dextran/Ficoll, yielding four times more neutrophils (average neutrophil counts: 18.5 × 103/μL vs. 4.5 × 103/μL), efficiently removing non‐neutrophil cells and reducing processing time (30–40 min vs. 70–90 min), although it incurred a higher cost (2.7 times). Conclusion Two cases of maternal anti‐FcγRIIIb isoantibodies, unrelated to NAIN, were identified. Although neutropenia has not been described in these cases, we emphasize the importance of identifying asymptomatic cases with the potential for severe neutropenia. Additionally, IMNS is introduced as a rapid, high‐yield, high‐purity neutrophil isolation technique, beneficial for serological assays detecting anti‐HNA antibodies.

Severe neonatal thrombocytopenia due to anti‐HPA‐4b alloantibodies: Third report described in a Caucasian mother

Generation of human antibodies targeting human platelet antigen (HPA)‐1a

Does anti‐HPA‐1a affect birthweight in fetal and neonatal alloimmune thrombocytopenia?

[Serological Diagnosis and Clinical Data Analysis of Neonatal Alloimmune Thrombocytopenia].

Characterization of a Human Platelet Antigen-1a–Specific Monoclonal Antibody Derived from a B Cell from a Woman Alloimmunized in Pregnancy

Hemolytic disease of the fetus and newborn due to alloanti-M: three Chinese case reports and a review of the literature.

Neonatal Alloimmune Thrombocytopenia Caused by Anti-Hpa Antibodies in Pregnant Chinese Women: a Study Protocol for a Multicentre, Prospective Cohort Trial

A case of haemolytic disease of the fetus and newborn attributed to a novel antigen in the RHAG blood group system

Analysis of maternal Fc gamma receptor IIIb isoantibodies using immunomagnetic negative selected neutrophils

A Phase 1b PK/PD Study to Demonstrate Antigen Elimination With RLYB212, a Monoclonal Anti-HPA-1a Antibody for FNAIT Prevention

Neonatal and Obstetrical Outcomes of Pregnancies Complicated by Alloimmunization

Characterization of blood bank and transfusion medicine practices for pregnant individuals with fetuses at risk of hemolytic disease in the United States

Successful management of maternal anti‐PP1Pk alloimmunization in pregnancy with therapeutic plasma exchange and intravenous immunoglobulin

Medical, Administrative, Financial, and Social Challenges in the Management of a Case of Hemolytic Disease of the Fetus Caused by a Rare Alloantibody in a Low-Resource Setting

Hemolytic disease of the fetus and newborn-a perspective of immunohematology

Targeted management of coexistent severe thrombophilias—A case report of a successful pregnancy despite paroxysmal nocturnal hemoglobinuria and hereditary protein C deficiency

Frequency of human platelet antigens (HPA) in the Greek population as deduced from the first registry of HPA‐typed blood donors

Anti-TPO antibodies diffusion through the placental barrier during pregnancy

Standard Compared With Extended Red Blood Cell Antigen Matching for Prevention of Subsequent Hemolytic Disease of the Fetus and Newborn: A Systematic Review

Maternal red blood cell alloimmunization prevalence in the United States

Hyporegenerative Anemia in Anti-M-associated Hemolytic Disease of the Fetus.